Appendix III: Nomenclature of Biotechnology Products
Published Online: 29 OCT 2004
DOI: 10.1002/0471704210.app3
Copyright © 2003 John Wiley & Sons, Inc.
Book Title

Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs
Additional Information
How to Cite
Ho, R. J. Y. and Gibaldi, M. (2004) Appendix III: Nomenclature of Biotechnology Products, in Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs, John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/0471704210.app3
Publication History
- Published Online: 29 OCT 2004
- Published Print: 20 JUN 2003
ISBN Information
Print ISBN: 9780471206903
Online ISBN: 9780471704218
- Summary
- Chapter
Keywords:
- nomenclature;
- biotechnology products
Summary
In collaboration with the Center for Biologics Evaluation and Research division of the United States Food and Drug Administration and the International Nonproprietary Names Committee of the World Health Organization, the United States Adopted Names (USAN) council created specific guidelines for coining names for biological and recombinant products, including interferons, interleukins, growth hormones, colony-stimulating factors, cytokines, and monoclonal antibodies. Some of these identifiers are included as prefixes, suffixes, and infixes (internally located) within the name of a new molecular entity to signify a different class of biologic molecules. This appendix provides definition of these prefixes, suffixes, and infixes in coining biotechnology products.
